Gene · 6045
Papers2,066
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,066
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomics reveals the potential mechanism of Tanshinone IIA in promoting the Ex Vivo expansion of human bone marrow mesenchymal stem cells. | Regen Ther | 2022 | 36475023 | PubTator, text mining | PubMed |
| ERK1/2 signalling dynamics promote neural differentiation by regulating chromatin accessibility and the polycomb repressive complex. | PLoS Biol | 2022 | 36455041 | PubTator, text mining | PubMed |
| PCGF1-PRC1 links chromatin repression with DNA replication during hematopoietic cell lineage commitment. | Nat Commun | 2022 | 36443290 | PubTator, text mining | PubMed |
| A Concise Review on Dysregulation of LINC00665 in Cancers. | Cells | 2022 | 36429005 | PubTator, text mining | PubMed |
| CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis. | Redox Biol | 2022 | 36427397 | PubTator, text mining | PubMed |
| RNA-activated protein cleavage with a CRISPR-associated endopeptidase. | Science | 2022 | 36423276 | PubTator, text mining | PubMed |
| LncRNA KCNQ1OT1 enhances the radioresistance of lung squamous cell carcinoma by targeting the miR-491-5p/TPX2-RNF2 axis. | J Thorac Dis | 2022 | 36389338 | PubTator, text mining | PubMed |
| Construction of cuproptosis-related lncRNAs/mRNAs model and prognostic prediction of hepatocellular carcinoma. | Am J Cancer Res | 2022 | 36381337 | PubTator, text mining | PubMed |
| Immunomodulatory Role of Thioredoxin Interacting Protein in Cancer's Impediments: Current Understanding and Therapeutic Implications. | Vaccines (Basel) | 2022 | 36366411 | PubTator, text mining | PubMed |
| Mining Transcriptomic Data to Uncover the Association between CBX Family Members and Cancer Stemness. | Int J Mol Sci | 2022 | 36361869 | PubTator, text mining | PubMed |
| CircRNAs in Tumor Radioresistance. | Biomolecules | 2022 | 36358938 | PubTator, text mining | PubMed |
| Factors and Mechanisms That Influence Chromatin-Mediated Enhancer-Promoter Interactions and Transcriptional Regulation. | Cancers (Basel) | 2022 | 36358822 | PubTator, text mining | PubMed |
| Deciphering the role of precursor miR-12136 and miR-8485 in the progression of intellectual disability (ID). | IBRO Neurosci Rep | 2022 | 36345471 | PubTator, text mining | PubMed |
| USP7 regulates the ncPRC1 Polycomb axis to stimulate genomic H2AK119ub1 deposition uncoupled from H3K27me3. | Sci Adv | 2022 | 36332031 | PubTator, text mining | PubMed |
| BAP1 in cancer: epigenetic stability and genome integrity. | Discov Oncol | 2022 | 36318367 | PubTator, text mining | PubMed |
| USP7 substrates identified by proteomics analysis reveal the specificity of USP7. | Genes Dev | 2022 | 36302555 | PubTator, text mining | PubMed |
| Epigenetic Regulation by Polycomb Complexes from Drosophila to Human and Its Relation to Communicable Disease Pathogenesis. | Int J Mol Sci | 2022 | 36293135 | PubTator, text mining | PubMed |
| CBX Family Members in Two Major Subtypes of Renal Cell Carcinoma: A Comparative Bioinformatic Analysis. | Diagnostics (Basel) | 2022 | 36292141 | PubTator, text mining | PubMed |
| Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature. | Biomedicines | 2022 | 36289829 | PubTator, text mining | PubMed |
The Oncogenic and Tumor Suppressive Long Non-Coding RNA-microRNA-Messenger RNA Regulatory Axes Identified by Analyzing Multiple Platform Omics Data from Cr(VI)-Transformed Cells and Their Implications in Lung Cancer. | Biomedicines | 2022 | 36289596 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6045/papers?page=17